|May have been subject to quarantine and/or additional testing either listed below or not. See accompanying documents for details.|
|Including blood products with serological and highly sensitive nucleic acid amplification technology testing on viruses according to current regulations (e.g. for Germany decision of the PEI "Prevention of drug risks, Graduated plan level 2" of April 5th, 2023)|
|Secondary testing at the end of a quarantine period according to current local regulations or approved study protocols. See "Guide to the Preparation, Use and Quality Assurance of Blood Components".|
Up to rel. 1.7.12: "Quarantine according to current local regulations. See 'Guide to the Preparation, Use and Quality Assurance of Blood Components'".
|Tested negative for bacteria|
|Product was tested negative for bacterial contamination|